Research Center on Health System, National Institute of Public Health, Cuernavaca, Morelos, México.
PLoS One. 2013 Jul 12;8(7):e68443. doi: 10.1371/journal.pone.0068443. Print 2013.
The rapid growth of diabetes in middle-income countries is generating disparities in global health. In this context we conducted a study to quantify the health disparities from the economic burden of diabetes in México. Evaluative research based on a longitudinal design, using cost methodology by instrumentation. For the estimation of epidemiological changes during the 2010-2012 period, several probabilistic models were developed using the Box-Jenkins technique. The financial requirements were obtained from expected case management costs by disease and the application of an econometric adjustment factor to control the effects of inflation. Comparing the economic impact in 2010 versus 2012 (p<0.05), there was a 33% increase in financial requirements. The total amount for diabetes in 2011 (US dollars) was $7.7 billion. It includes $3.4 billion in direct costs and $4.3 in indirect costs. The total direct costs were $.4 billion to the Ministry of Health (SSA), serving the uninsured population; $1.2 to the institutions serving the insured population (Mexican Institute for Social Security-IMSS-, and Institute for Social Security and Services for State Workers-ISSSTE-); $1.8 to users; and $.1 to Private Health Insurance (PHI). If the risk factors and the different health care models remain as they currently are in the analyzed institutions, health disparities in terms of financial implications will have the greatest impact on users' pockets. In middle-income countries, health disparities generated by the economic burden of diabetes is one of the main reasons for catastrophic health expenditure. Health disparities generated by the economic burden of diabetes suggests the need to design and review the current organization of health systems and the relevance of moving from biomedical models and curative health care to preventive and socio-medical models to meet expected challenges from diseases like diabetes in middle-income countries.
糖尿病在中等收入国家的迅速增长正在造成全球健康方面的差距。在此背景下,我们进行了一项研究,以量化墨西哥糖尿病的经济负担造成的健康差距。这是一项基于纵向设计的评估性研究,使用仪器成本方法。为了估计 2010-2012 年期间的流行病学变化,使用 Box-Jenkins 技术开发了几种概率模型。根据疾病的预期病例管理成本获得资金需求,并应用计量经济学调整因素来控制通货膨胀的影响。与 2010 年相比,2012 年(p<0.05)的经济影响增加了 33%。2011 年糖尿病的总金额(美元)为 77 亿美元。其中包括 34 亿美元的直接费用和 43 亿美元的间接费用。卫生部(SSA)为未参保人群服务的直接总成本为 40 亿美元;为参保人群服务的机构(墨西哥社会保障研究所-IMSS-和州工人工会社会保障和服务研究所-ISSSTE-)的直接总成本为 12 亿美元;使用者的直接总成本为 18 亿美元;私人医疗保险(PHI)为 1 亿美元。如果风险因素和不同的医疗保健模式保持在分析机构中的现状,那么在经济负担方面的健康差距将对使用者的口袋产生最大影响。在中等收入国家,糖尿病的经济负担造成的健康差距是灾难性卫生支出的主要原因之一。糖尿病的经济负担造成的健康差距表明,有必要设计和审查卫生系统的当前组织,以及从生物医学模式和治疗性医疗保健向预防性和社会医学模式转变的重要性,以应对糖尿病等疾病在中等收入国家带来的预期挑战。